Spouses who have a husband or wife dealing with cancer may see their own physical and psychological health deteriorate over time, a new study suggests.

Swedish researchers found that among more than 11,000 spouses of cancer patients, the overall rate of healthcare use increased in the two years following the cancer diagnosis — particularly when a spouse was suffering from colon or lung cancer.

New insight into how primary lung cancer turns into invasive, or metastatic, cancer could lead to treatments that improve patient survival, U.S. scientists say.

The research team at the University of Texas M.D. Anderson Cancer Center found that lung cancer becomes invasive by suppressing a type of microRNA that normally keeps tumors in a non-metastatic state.

West Virginia University researchers will use $1 million in stimulus money to try to improve the survival rate for lung cancer patients whose tumors return.

Computer scientist Lan Guo says five-year survival rates for lung cancer patient are already low. But when the cancer returns — as it does in up to half of patients — it’s almost always fatal.

My life with cancer, right now, has many limitations.

I no longer see patients because of my pain medication regimen. I have very limited reserves of energy and must rest after a single flight of stairs or making the bed in the morning. I can’t feel my feet (neuropathy from chemotherapy) or the back of my left leg (probably nerve damage related to metastatic disease in my spine). I can’t stand for more than a minute without uncontrollable back pain so it’s very difficult for me to do something as simple as go to the grocery store.

Nearly half of the lung cancer patients have malignant pleural effusion, which causes enormous pain and greatly deteriorates patients’ quality of life. Greek scientist Georgios Stathopoulos has discovered the cause of this complication, which provided possibility for prevention.

Stathopoulos presented his research progress at a press conference during the European Lung Disease Congress being held here on Wednesday. He said that the beginning of the advanced lung cancer is often accompanied by respiratory tract infection, which further forms malignant pleural effusion.

Winding through country roads, up and down the rolling hills of the Kentucky landscape, in the middle of September is something expected of a retired Sellersburg couple. What is not expected, is when the couple is working their way through the countryside by pedaling in their twentieth mile of a bicycle ride.

But that’s just what Jan and Judd Penske are doing and it’s for a good cause, too…

A young Bethesda family is taking their personal battle with lung cancer to the National Mall in November, hosting a fundraising walk to benefit lung cancer research.

Breathe Deep DC — a 5k walk on the National Mall on November 15th — was conceived by Jerry Sorkin, a Bethesda father of two, who was diagnosed with Stage IV lung cancer two years ago. A non-smoker, Sorkin was treated for Hodgkin’s disease, another type of cancer, in high school and again in college. The radiation that saved his life in the early 1980s is the likely cause of his lung cancer.

A committee of scientists led by Johns Hopkins investigators has published a new guide to the biology, diagnosis and treatment of lung cancer in never-smokers, fortifying measures for what physicians have long known is a very different disease than in smokers.

“It is becoming increasingly clear that the genetic, cellular, and molecular nature of lung cancer in many never-smokers is different from that of smoking-related lung cancers, and there is good evidence now that the best treatment and prevention strategies for never-smokers may be different as well,” says Charles M. Rudin, M.D., Ph.D., associate director for Clinical Research at the Johns Hopkins Kimmel Cancer Center. Lung cancer in never-smokers is the sixth leading cause of cancer-related deaths in the U.S.

… Oncothyreon is developing a potential cancer vaccine Stimuvax. The investigational therapeutic cancer vaccine is being developed by Merck KGaA of Darmstadt, Germany, under a license agreement with Oncothyreon. MUC1, a protein antigen is over expressed in all cancer cells, including lung, breast and colorectal. Stimuvax is thought to work by stimulating the body’s immune system to identify and destroy cancer cells expressing MUC1.

Hispanics and Latinos have a unique cancer profile that means they are less likely to get the four most common cancers, but are more likely to develop cancers related to infection, according to a report published Sept. 15 by the American Cancer Society…